Acute haemorrhagic diarrhoea syndrome in dogs: amoxicillin-clavulanate vs placebo — POSSIBLE (the treatment made no difference)

In dogs with AHDS without signs of sepsis, does amoxicillin-clavulanate speed recovery or shorten hospitalisation vs placebo?

Shelf #161 · gate-verified and displayed under the developer's blinded-trial rule

POSSIBLE (the treatment made no difference): In dogs with acute haemorrhagic diarrhoea and no signs of sepsis, amoxicillin/clavulanic acid did not change the outcome. In a prospective, placebo-controlled, blinded study at a university clinic in Munich — 60 dogs enrolled, 53 completing — there was no significant difference between the antibiotic and placebo groups in mortality rate, dropout rate, duration of hospitalization, or severity of clinical signs on any individual day or over the course of disease. The trial's record uses the older name haemorrhagic gastroenteritis (HGE) for the syndrome now usually called AHDS. This is one moderately sized trial, so the no-difference stamp is POSSIBLE rather than higher; but within it, every measured outcome pointed the same way, which is why the stewardship conclusion — antibiotics may not be needed in aseptic/sepsis-free cases — is the shelf's working message. Drafted Nov 10, 2026 (VetMed build, topic #161); all figures from abstracts fetched and verified at drafting.

Unterer 2011: no difference in mortality, hospitalisation or clinical severity between amoxicillin/clavulanate and placebo in 53 completing dogs

Prospective, placebo-controlled, blinded study, patients randomly divided (record's own wording); indexed as Randomized Controlled Trial

Who: Dogs: 60 dogs diagnosed with haemorrhagic gastroenteritis (the syndrome now usually called acute haemorrhagic diarrhoea syndrome) between 2007 and 2009 at the Clinic of Small Animal Medicine, LMU University of Munich, Germany — inclusion required acute hemorrhagic diarrhea of <3 days; dogs pretreated with antibiotics, with signs of sepsis, or with any disease known to cause bloody diarrhea were excluded. Patients were randomly divided into treatment (amoxicillin/clavulanic acid for 7 days) and placebo groups; 53 of 60 dogs completed the study.

Result: No significant difference between treatment groups concerning mortality rate, dropout rate, duration of hospitalization, or severity of clinical signs (scored on a newly developed HGE index), either on any individual day or over the course of disease, was observed. The authors conclude that in some dogs with HGE that show no signs of sepsis, antibiotics may not change the case outcome or time to recovery.

Watch out: Single trial carries this shelf (stated on its face), and its result applies only to dogs without signs of sepsis — septic dogs were excluded by design, so this shelf must never be read as evidence against antibiotics in a septic AHDS dog. Seven of 60 enrolled dogs did not complete the study. The record does not use the word 'double-blind'; it states a prospective, placebo-controlled, blinded study with random allocation, and is indexed as a Randomized Controlled Trial.

Unterer S, Strohmeyer K, Kruse BD, Sauter-Louis C, Hartmann K. Treatment of aseptic dogs with hemorrhagic gastroenteritis with amoxicillin/clavulanic acid: a prospective blinded study. J Vet Intern Med. 2011;25(5):973-9. PMID: 21781168. Registry ID: none in the record. MeSH: Amoxicillin-Potassium Clavulanate Combination · Animals · Anti-Bacterial Agents · Diarrhea · Dog Diseases · Dogs · Female · Gastroenteritis · Gastrointestinal Hemorrhage · Male · Prospective Studies · Sepsis · Treatment Outcome

Synthesis: for the sepsis-free AHDS dog, the antibiotic changed nothing that was measured

Synthesis

Who: Synthesis of the card above: Unterer 2011 (prospective, placebo-controlled, blinded study, 60 enrolled / 53 completing dogs with acute haemorrhagic diarrhoea and no signs of sepsis, single university clinic).

Result: Mortality, hospitalisation duration and day-by-day clinical severity all failed to separate antibiotic from placebo — a coherent null across outcomes, not a single missed endpoint. That coherence is what makes a single 53-dog trial worth shelving at POSSIBLE (the treatment made no difference): it directly answers the commonest 'just in case' antibiotic decision in canine GI practice, and its direction aligns with antimicrobial-stewardship concerns about resistance and adverse drug reactions that the trial's background names. A larger multicentre replication would be needed to raise the stamp.

Watch out: The excluded groups are the boundary of this shelf: dogs with signs of sepsis, dogs pretreated with antibiotics, and dogs whose bloody diarrhoea had another known cause were not studied and are not covered by the null result.

Synthesis of Unterer S et al. PMID: 21781168. Registry ID as on the individual card.

Back to the library index · VetMed home

VetMed is an educational resource, not veterinary advice.